| Less fat reduction per unit weight loss in type 2 diabetic compared with nondiabetic obese individuals completing a very-low-calorie diet program. | |
| | |
MedLine Citation:
|
PMID: 22146094 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The objective was to compare weight loss and change in body composition in obese subjects with and without type 2 diabetes mellitus during a very-low-calorie diet (VLCD) program. Seventy weight-matched subjects with diabetes or normal fasting glucose (controls) participated in a 24-week VLCD study. Primary end points were changes in anthropometry, body composition, and fasting plasma insulin and β-hydroxybutyrate concentrations. Fifty-one subjects (24 with diabetes) completed the study. No difference in weight loss between the 2 groups at 24 weeks was found by intention-to-treat analysis. Both groups completing the study per protocol had near-identical weight change during the program, with similar weight loss at 24 weeks (diabetes: 8.5 ± 1.3 kg vs control: 9.4 ± 1.2 kg, P = .64). Change in fat mass index correlated with change in body mass index (BMI) in both groups (diabetes: r = 0.878, control: r = 0.920, both P < .001); but change in fat mass index per unit change in BMI was less in the diabetic group compared with controls (0.574 vs 0.905 decrease, P = .003), which persisted after adjusting for age, sex, and baseline BMI (P = .008). Insulin concentrations remained higher and peak β-hydroxybutyrate concentrations were lower in the diabetic compared with the control group. While following a 24-week VLCD program, obese subjects with and without diabetes achieved comparable weight loss; but the decrease in adiposity per unit weight loss was attenuated in diabetic subjects. Hyperinsulinemia may have inhibited lipolysis in the diabetic group; however, further investigation into other factors is needed. |
| | |
Authors:
|
Scott T Baker; George Jerums; Luke A Prendergast; Sianna Panagiotopoulos; Boyd J Strauss; Joseph Proietto |
Related Documents
:
|
10770174 - Effects of insulin-like growth factor i (igf-i) therapy on body composition and insulin... 17251074 - Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mi... 20950884 - Prevalence and predictors of osteopenia and osteoporosis in postmenopausal chinese wome... 21615774 - A possible role for the thioredoxin system in the protective effects of probucol in the... 2335184 - The higher frequency of type i (insulin-dependent) diabetes in fathers than in mothers ... 6876184 - Effects of increased cardiac work on pyruvate dehydrogenase activity in hearts from dia... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-5 |
Journal Detail:
|
Title: Metabolism: clinical and experimental Volume: - ISSN: 1532-8600 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-7 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375267 Medline TA: Metabolism Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Affiliation:
|
Endocrine Centre, Austin Health, Heidelberg Repatriation Hospital Campus, Heidelberg West, Victoria 3081, Australia; Department of Medicine (Austin Health), University of Melbourne, Heidelberg West, Victoria 3081, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies.
Next Document: Prediction of gestational diabetes mellitus at 24 to 28 weeks of gestation by using first-trimester ...